W J Hierholzer|D W Barry - JoVE Visualize

Showing results (71-80 of 79) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 79 results.

Infection Control and Hospital Epidemiology|March 24, 1998

Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Healthcare Epidemiology of AmericaW E Scheckler, D Brimhall, A S Buck, et al.

Journal of Acquired Immune Deficiency Syndromes|January 1, 1988

HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trailW P Parks, E S Parks, M A Fischl, et al.

The Journal of Infectious Diseases|December 1, 1977

Correlation of laboratory studies with clinical responses to A/New Jersey influenza vaccinesF A Ennis, R E Mayner, D W Barry, et al.

Antimicrobial Agents and Chemotherapy|July 1, 1987

Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificityM N Ellis, P M Keller, J A Fyfe, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 1, 1985

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitroH Mitsuya, K J Weinhold, P A Furman, et al.

American Journal of Epidemiology|July 1, 1976

Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in manD W Barry, R E Mayner, E Staton, et al.

American Journal of Epidemiology|July 1, 1976

Comparative trial of influenza vaccines. II. Adverse reactions in children and adultsD W Barry, R E Mayner, H D Hochstein, et al.

Lancet (London, England)|March 15, 1986

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complexR Yarchoan, R W Klecker, K J Weinhold, et al.

Antimicrobial Agents and Chemotherapy|December 22, 1999

Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1G M Szczech, P Furman, G R Painter, et al.

Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 79 results.

Infection Control and Hospital Epidemiology|March 24, 1998

Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Healthcare Epidemiology of AmericaW E Scheckler, D Brimhall, A S Buck, et al.

Journal of Acquired Immune Deficiency Syndromes|January 1, 1988

HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trailW P Parks, E S Parks, M A Fischl, et al.

The Journal of Infectious Diseases|December 1, 1977

Correlation of laboratory studies with clinical responses to A/New Jersey influenza vaccinesF A Ennis, R E Mayner, D W Barry, et al.

Antimicrobial Agents and Chemotherapy|July 1, 1987

Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificityM N Ellis, P M Keller, J A Fyfe, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 1, 1985

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitroH Mitsuya, K J Weinhold, P A Furman, et al.

American Journal of Epidemiology|July 1, 1976

Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in manD W Barry, R E Mayner, E Staton, et al.

American Journal of Epidemiology|July 1, 1976

Comparative trial of influenza vaccines. II. Adverse reactions in children and adultsD W Barry, R E Mayner, H D Hochstein, et al.

Lancet (London, England)|March 15, 1986

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complexR Yarchoan, R W Klecker, K J Weinhold, et al.

Antimicrobial Agents and Chemotherapy|December 22, 1999

Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1G M Szczech, P Furman, G R Painter, et al.

Pageof 8